Use of preclinical assays to predict risk of drug-induced torsades de pointes.
about
Impact of hypokalemia on electromechanical window, excitation wavelength and repolarization gradients in guinea-pig and rabbit heartsHigh-precision recording of the action potential in isolated cardiomyocytes using the near-infrared fluorescent dye di-4-ANBDQBS.Anti-anginal and anti-ischemic effects of late sodium current inhibitionIn vitro cardiovascular effects of dihydroartemisin-piperaquine combination compared with other antimalarialsAugmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidineKey clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes.The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients.Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC.
P2860
Q28542455-B0BDC5F9-4DC8-443D-9949-3AC203D3F37EQ30497050-12E24E9A-A21F-4B57-889E-46A9A65CDF1FQ35147202-503C34AB-9187-45CE-A478-17AF850720DBQ36018689-1B134275-6AC8-46FB-A418-CE3BF3E1ACFEQ36628319-129FD51B-4D9E-4738-AF85-8AD170EEFB48Q37159534-33F296AE-D313-4DBB-AF7C-DA3F5AF2DACCQ37184414-F24309E7-CFE5-40CB-8B7A-755D4BACA46AQ37613422-4912B19E-28DE-4C2B-A34A-A4A70E2AECE2Q43059195-3E869271-94EF-4FB0-8C38-D9768DDA0A97Q49164511-188A37DB-E91F-49DF-A909-E2A0C769CB2D
P2860
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@ast
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@en
type
label
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@ast
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@en
prefLabel
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@ast
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@en
P2093
P1433
P1476
Use of preclinical assays to predict risk of drug-induced torsades de pointes.
@en
P2093
John C Shryock
Luiz Belardinelli
Yejia Song
P304
P356
10.1016/J.HRTHM.2004.10.032
P433
P577
2005-11-01T00:00:00Z